| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.1M | -12.2% |
| Cost of Revenue | $1.2M | -25.7% |
| Gross Profit | $3.9M | -7.0% |
| R&D Expense | $2.6M | +8.5% |
| SG&A Expense | $8.7M | -5.5% |
| Operating Income | -$17.7M | -29.8% |
| Interest Expense | $561K | +4.6% |
| Pre-tax Income | -$14.3M | -75.4% |
| Income Tax | $0 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.7M | -72.1% |
| Accounts Receivable | $416K | -81.3% |
| Inventory | $1.3M | -16.2% |
| Current Assets | $7.3M | -64.2% |
| Total Assets | $10.6M | -68.5% |
| Current Liabilities | $18.0M | +67.4% |
| Total Liabilities | $18.1M | -15.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.6M | +65.9% |
| Capital Expenditures | $25K | — |
| Investing Cash Flow | -$25K | — |
| Financing Cash Flow | -$7.0M | -160.7% |
| Free Cash Flow | -$2.6M | — |
| — |
| Net Income | -$14.3M | -75.4% |
| EPS (Basic) | -$3.34 | +47.4% |
| EPS (Diluted) | -$3.34 | +47.4% |
| Stockholders' Equity |
| -$7.5M |
| -161.9% |